Luminza, Cornelio T.
HRN: 23-64-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/02/2023
09/08/2023
IVT
500mg
Q8
T/c Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes